1. Home
  2. NMCO vs ZVRA Comparison

NMCO vs ZVRA Comparison

Compare NMCO & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMCO
  • ZVRA
  • Stock Information
  • Founded
  • NMCO 2019
  • ZVRA 2006
  • Country
  • NMCO United States
  • ZVRA United States
  • Employees
  • NMCO N/A
  • ZVRA N/A
  • Industry
  • NMCO Finance/Investors Services
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NMCO Finance
  • ZVRA Health Care
  • Exchange
  • NMCO Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • NMCO 560.1M
  • ZVRA 627.7M
  • IPO Year
  • NMCO N/A
  • ZVRA 2015
  • Fundamental
  • Price
  • NMCO $10.33
  • ZVRA $9.02
  • Analyst Decision
  • NMCO
  • ZVRA Strong Buy
  • Analyst Count
  • NMCO 0
  • ZVRA 10
  • Target Price
  • NMCO N/A
  • ZVRA $22.67
  • AVG Volume (30 Days)
  • NMCO 207.6K
  • ZVRA 1.6M
  • Earning Date
  • NMCO 01-01-0001
  • ZVRA 08-12-2025
  • Dividend Yield
  • NMCO 5.43%
  • ZVRA N/A
  • EPS Growth
  • NMCO N/A
  • ZVRA N/A
  • EPS
  • NMCO N/A
  • ZVRA N/A
  • Revenue
  • NMCO N/A
  • ZVRA $62,020,000.00
  • Revenue This Year
  • NMCO N/A
  • ZVRA $329.57
  • Revenue Next Year
  • NMCO N/A
  • ZVRA $55.29
  • P/E Ratio
  • NMCO N/A
  • ZVRA N/A
  • Revenue Growth
  • NMCO N/A
  • ZVRA 161.81
  • 52 Week Low
  • NMCO $8.52
  • ZVRA $6.19
  • 52 Week High
  • NMCO $11.64
  • ZVRA $13.16
  • Technical
  • Relative Strength Index (RSI)
  • NMCO 56.57
  • ZVRA 38.21
  • Support Level
  • NMCO $10.08
  • ZVRA $9.16
  • Resistance Level
  • NMCO $10.40
  • ZVRA $9.48
  • Average True Range (ATR)
  • NMCO 0.08
  • ZVRA 0.57
  • MACD
  • NMCO 0.02
  • ZVRA -0.09
  • Stochastic Oscillator
  • NMCO 78.13
  • ZVRA 18.99

About NMCO Nuveen Municipal Credit Opportunities Fund

Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: